<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35822272</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1473-2300</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The Journal of international medical research</Title><ISOAbbreviation>J Int Med Res</ISOAbbreviation></Journal><ArticleTitle>Quality of life and persistence of COVID-19 symptoms 90 days after hospital discharge.</ArticleTitle><Pagination><StartPage>3000605221110492</StartPage><MedlinePgn>3000605221110492</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">03000605221110492</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/03000605221110492</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We aimed to describe the persistence of symptoms in coronavirus disease 2019 (COVID-19) and quality of life (QoL) among patients 90 days after their discharge from the hospital for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and to determine differences in QoL domains concerning the absence or presence of persistent symptoms.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">To measure QoL, we used a validated Spanish version of the 36-item Short Form Health Survey (SF-36).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included 141 patients. Ninety days after discharge, COVID-19 symptoms persisted in 107 patients (75.9%), with fatigue (55.3%) and joint pain (46.8%) being the most frequent. According to the SF-36, the role-physical score was the dimension with the lowest values (median score, 25; interquartile range, 0-75). Patients with joint pain, fatigue, and dyspnea had lower scores than patients without those symptoms, with 10 of the 13 evaluated SF-36 scales showing lower levels.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Ninety days after hospital discharge from COVID-19 reference centers, most patients had persistent symptoms and had lower SF-36 scores than patients without symptoms. It is important to follow-up patients discharged from the hospital after SARS-CoV-2 infection, ideally through a post-COVID-19 health care clinic and rehabilitation program, to improve QoL in these patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mu&#xf1;oz-Corona</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Fellow of the General Directorate of Quality and Health Education, Ministry of Health, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guti&#xe9;rrez-Canales</LastName><ForeName>Lizeth Guadalupe</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Guanajuato, Guanajuato, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortiz-Ledesma</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital Regional de Alta Especialidad del Baj&#xed;o, Le&#xf3;n Guanajuato, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-Navarro</LastName><ForeName>Liz Jovanna</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital Regional de Alta Especialidad del Baj&#xed;o, Le&#xf3;n Guanajuato, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mac&#xed;as</LastName><ForeName>Alejandro E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Medicine and Nutrition, University of Guanajuato, Le&#xf3;n, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scavo-Montes</LastName><ForeName>David Alejandro</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Hospital Estatal de Atenci&#xf3;n COVID-19, Le&#xf3;n Guanajuato, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guan&#xed;-Guerra</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-6494-5511</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of Guanajuato, Guanajuato, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Research, Hospital Regional de Alta Especialidad del Baj&#xed;o, Le&#xf3;n Guanajuato, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Int Med Res</MedlineTA><NlmUniqueID>0346411</NlmUniqueID><ISSNLinking>0300-0605</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018771" MajorTopicYN="N">Arthralgia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">36-item Short Form Health Survey</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">coronavirus disease 2019</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">persistent COVID-19 symptoms</Keyword><Keyword MajorTopicYN="N">severe acute respiratory syndrome coronavirus 2</Keyword></KeywordList><CoiStatement><b>Declaration of conflicting interest:</b> The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>13</Day><Hour>2</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35822272</ArticleId><ArticleId IdType="pmc">PMC9284218</ArticleId><ArticleId IdType="doi">10.1177/03000605221110492</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. COVID-19 Weekly Epidemiological Update. August 29, 2021.</Citation></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, et al.. Post-discharge symptoms and rehabilitation needs in survivors of COVID&#x2010;19 infection: A cross&#x2010;sectional evaluation. J Med Virol 2021; 93: 1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Demeco A, Marotta N, Barletta M, et al.. Rehabilitation of patients post-COVID-19 infection: a literature review. J Int Med Res 2020; 48: 0300060520948382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7450453</ArticleId><ArticleId IdType="pubmed">32840156</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlake JH, Wesselius S, Van Genderen ME, et al.. Psychological distress and health-related quality of life in patients after hospitalization during the COVID-19 pandemic: A single-center, observational study. PLoS One 2021; 16: e0255774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8357130</ArticleId><ArticleId IdType="pubmed">34379644</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al.. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 2021; 11: 16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al.. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397: 220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O&#x2019;Malley M, et al.. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Ann Intern Med 2021; 174: 576&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs LG, Gourna Paleoudis E, Lesky-Di Bari D, et al.. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One 2020; 15: e0243882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Kream RM, Stefano GB. Long-Term Respiratory and Neurological Sequelae of COVID-19. Med Sci Monit 2020; 26: e928996.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7643287</ArticleId><ArticleId IdType="pubmed">33177481</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K, Zhang W, Yang Y, et al.. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement Ther Clin Pract 2020; 39: 101166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118596</ArticleId><ArticleId IdType="pubmed">32379637</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et al.. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect 2020; 81: e4&#x2013;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Elm E, Altman DG, Egger M, et al.. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. Ann Intern Med 2007; 147: 573&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pubmed">17938396</ArticleId></ArticleIdList></Reference><Reference><Citation>Gait&#xe1;n-Rossi P, P&#xe9;rez-Hern&#xe1;ndez V, Vilar-Compte M, et al.. Prevalencia mensual de trastorno de ansiedad generalizada durante la pandemia por Covid-19 en M&#xe9;xico. Salud Publica Mex 2021; 63: 478&#x2013;485.</Citation><ArticleIdList><ArticleId IdType="pubmed">35077102</ArticleId></ArticleIdList></Reference><Reference><Citation>Baader MT, Molina F JL, Venezian BS, et al.. Validaci&#xf3;n y utilidad de la encuesta PHQ-9 (Patient Health Questionnaire) en el diagn&#xf3;stico de depresi&#xf3;n en pacientes usuarios de atenci&#xf3;n primaria en Chile. Revista Chilena de Neuro-Psiquiatr&#xed;a 2012; 50: 10&#x2013;22.</Citation></Reference><Reference><Citation>Tadeo-&#xc1;lvarez MA, Mungu&#xed;a-Ort&#xed;z CD, Ben&#xed;tez-L&#xf3;pez V, et al.. Presence of depressive symptoms in medical students in a Mexican public university. Salud Mental 2019; 42: 131&#x2013;136.</Citation></Reference><Reference><Citation>Z&#xfa;&#xf1;iga M, Carrillo-Jim&#xe9;nez G, Fos P, et al.. Evaluaci&#xf3;n del estado de salud con la Encuesta Evaluaci&#xf3;n del estado de salud con la Encuesta SF-36: resultados preliminares en M&#xe9;xico. Salud Publica Mex 1999; 41: 110&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">10343514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection. Med Care 1992; 30: 473&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pubmed">1593914</ArticleId></ArticleIdList></Reference><Reference><Citation>Barile JP, Horner-Johnson W, Krahn G, et al.. Measurement characteristics for two health-related quality of life measures in older adults: The SF-36 and the CDC Healthy Days items. Disabil Health J 2016; 9: 567&#x2013;574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5292245</ArticleId><ArticleId IdType="pubmed">27259343</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Core MA, Ahn J, Wukich DK, et al.. Gender Differences on SF-36 Patient-Reported Outcomes of Diabetic Foot Disease. Int J Low Extrem Wounds 2018; 17: 87&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">29929411</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware J, Kosinski M, Keller S. SF-36 Physical and Mental health summary scales: a user&#xb4;s manual. 5th ed. Boston: Health Assessment Lab, 1994.</Citation></Reference><Reference><Citation>Farivar SS, Cunningham WE, Hays RD. Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.1. Health Qual Life Outcomes 2007; 5: 54. DOI: 10.1186/1477-7525-5-54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2065865</ArticleId><ArticleId IdType="pubmed">17825096</ArticleId></ArticleIdList></Reference><Reference><Citation>Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann Med 2001; 33: 350&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">11491194</ArticleId></ArticleIdList></Reference><Reference><Citation>VassarStats. Website for
Statistical Computation. http://vassarstats.net/
(accessed May 9, 2021).</Citation></Reference><Reference><Citation>Parohan M, Yaghoubi S, Seraji A, et al.. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. The Aging Male 2020; 23: 1416&#x2013;1424.</Citation><ArticleIdList><ArticleId IdType="pubmed">32508193</ArticleId></ArticleIdList></Reference><Reference><Citation>Peckham H, De Gruijter NM, Raine C, et al.. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun 2020; 11: 6317. DOI: 10.1038/s41467-020-19741-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7726563</ArticleId><ArticleId IdType="pubmed">33298944</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Ding M, Dong X, et al.. Risk factors for severe and critically ill COVID&#x2010;19 patients: A review. Allergy 2021; 76: 428&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pubmed">33185910</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashedi J, Mahdavi Poor B, Asgharzadeh V, et al.. Risk Factors for COVID-19. Infez Med 2020; 4: 469&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257620</ArticleId></ArticleIdList></Reference><Reference><Citation>Tadic M, Cuspidi C, Sala C. COVID&#x2010;19 and diabetes: Is there enough evidence? J Clin Hypertens (Greenwich) 2020; 22: 943&#x2013;948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300807</ArticleId><ArticleId IdType="pubmed">32472662</ArticleId></ArticleIdList></Reference><Reference><Citation>Salazar M, Barochiner J, Espeche W, et al.. COVID-19, hipertensi&#xf3;n y enfermedad cardiovascular. Hipertens Riesgo Vasc 2020; 37: 176&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301092</ArticleId><ArticleId IdType="pubmed">32591283</ArticleId></ArticleIdList></Reference><Reference><Citation>Daher A, Balfanz P, Cornelissen C, et al.. Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae. Respir Med 2020; 174: 106197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7573668</ArticleId><ArticleId IdType="pubmed">33120193</ArticleId></ArticleIdList></Reference><Reference><Citation>Frithiof R, Rostami E, Kumlien E, et al.. Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study. Clin Neurophysiol 2021; 132: 1733&#x2013;1740.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8012169</ArticleId><ArticleId IdType="pubmed">33875374</ArticleId></ArticleIdList></Reference><Reference><Citation>Akter F, Mannan A, Mehedi HMH, et al.. Clinical characteristics and short-term outcomes after recovery from COVID-19 in patients with and without diabetes in Bangladesh. Diabetes Metab Syndr 2020; 14: 2031&#x2013;2038.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7575434</ArticleId><ArticleId IdType="pubmed">33113469</ArticleId></ArticleIdList></Reference><Reference><Citation>Carda S, Invernizzi M, Bavikatte G, et al.. COVID-19 pandemic. What should physical and rehabilitation medicine specialists do? A clinician&#x2019;s perspective. Eur J Phys Rehabil Med 2020; 56: 515&#x2013;524. DOI: 10.23736/S1973-9087.20.06317-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">32434314</ArticleId></ArticleIdList></Reference><Reference><Citation>Marotta N, Demeco A, Moggio L, et al.. Why is telerehabilitation necessary? A pre-post COVID-19 comparative study of ICF activity and participation. J Enabling Technologies 2021; 15: 117&#x2013;121.</Citation></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al.. Post-acute COVID-19 syndrome. Nature Medicine 2021; 27: 601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosales-Castillo A, Garc&#xed;a de los R&#xed;os C, Mediavilla Garc&#xed;a JD. Persistent symptoms after acute COVID-19 infection: importance of follow-up. Med Clin (Barc) 2021; 156: 35&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833449</ArticleId><ArticleId IdType="pubmed">33521308</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020; 324: 603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud R, Rahman MM, Rassel MA, et al.. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh. PLoS One 2021; 16: e0249644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8031743</ArticleId><ArticleId IdType="pubmed">33831043</ArticleId></ArticleIdList></Reference><Reference><Citation>Landi F, Carf&#xec; A, Benvenuto F, et al.. Predictive Factors for a New Positive Nasopharyngeal Swab Among Patients Recovered From COVID-19. Am J Prev Med 2021; 60: 13&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7500946</ArticleId><ArticleId IdType="pubmed">33041095</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M, Abo Omirah M, Hussein A, et al.. Assessment and characterisation of post&#x2010;COVID&#x2010;19 manifestations. Int J Clin Pract 2021; 75: e13746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Li X, Geng D, et al.. Cerebral Micro-Structural Changes in COVID-19 Patients &#x2013; An MRI-based 3-month Follow-up Study. EClinicalMedicine 2020; 25: 100484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, et al.. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect 2021; 27: 89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Moradi F, Enjezab B, Ghadiri-Anari A. The role of androgens in COVID-19. Diabetes Metab Syndr 2020; 14: 2003&#x2013;2006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7557269</ArticleId><ArticleId IdType="pubmed">33091758</ArticleId></ArticleIdList></Reference><Reference><Citation>Temperoni C, Grieco S, Pasquini Z, et al.. Clinical characteristics, management and health related quality of life in young to middle age adults with COVID-19. BMC Infect Dis 2021; 21: 134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7848882</ArticleId><ArticleId IdType="pubmed">33522907</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan X-Y, Zhang H, Huang LR, et al.. Evaluation of health-related quality of life and the related factors in a group of Chinese patients with interstitial lung diseases. PLoS One 2020; 15: e0236346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7417083</ArticleId><ArticleId IdType="pubmed">32726327</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutogniewska W, Jastrzebski D, Wyrwol J, et al.. Dyspnea and quality of life in patients referred for lung transplantation. Eur J Med Res 2010; 15: 76&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4360360</ArticleId><ArticleId IdType="pubmed">21147626</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez R, Balanz&#xe1;&#x2010;Mart&#xed;nez V, Luperdi SC, et al.. Short&#x2010;term neuropsychiatric outcomes and quality of life in COVID&#x2010;19 survivors. J Intern Med 2021; 621&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013333</ArticleId><ArticleId IdType="pubmed">33533521</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KY, Li T, Gong FH, et al.. Predictors of Health-Related Quality of Life and Influencing Factors for COVID-19 Patients, a Follow-Up at One Month. Front Psychiatry 2020; 11: 668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7360857</ArticleId><ArticleId IdType="pubmed">32733299</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlake JH, Wesselius S, Van Genderen ME, et al.. Psychological distress and health-related quality of life in patients after hospitalization during the COVID-19 pandemic: A single-center, observational study. PLoS One 2021; 16: e0255774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8357130</ArticleId><ArticleId IdType="pubmed">34379644</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, et al.. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 2020; 7: 611&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>